Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call


2021-10-14 12:00:08 BioSpace


WILMINGTON, Mass.---- Charles River Laboratories International, Inc. will release third-quarter 2021 financial results on Wednesday, November 3rd, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 3rd, at 9:00 a.m. ET. Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at A replay will be accessible through the same website. About Charles River Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit View source version on Investor Relations: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 Source: Charles River Laboratories International, Inc. View this news release online at:
马萨诸塞州威尔明顿。查尔斯河国际实验室公司将于11月3日星期三开盘前发布2021年第三季度财务业绩。已经安排在美国东部时间11月3日星期三上午9点召开电话会议讨论这一信息。 投资者将有机会通过公司网站的投资者关系部分收听电话会议的现场直播。重播将通过同一网站访问。 关于查尔斯河 Charles River提供重要的产品和服务,帮助全球制药和生物技术公司、政府机构和领先的学术机构加快研究和药物开发工作。我们敬业的员工专注于为客户提供他们所需要的改善和加速新疗法的发现、早期开发和安全生产,以满足需要的患者的需要。欲了解更多关于我们独特的产品组合和广泛的服务,请访问。 在businesswire.com查看源代码版本: 投资者关系: 托德·斯宾塞 公司副总裁,投资者关系 781.222.6455 资料来源:查尔斯河国际实验室公司。 在网上查看此新闻稿: